TrialAnnals of the rheumatic diseases2014

A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients.

Doruk Erkan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.